CSS LLC’s AstraZeneca AZN Stock Holding History

CSS LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,100	Closed	-$248K	–	727
2016 Q2	$248K	Hold	4,100	–	–	0.02%	529
2016 Q1	$231K	Sell	4,100 -4,100	-50%	-$246K	0.01%	505
2015 Q4	$556K	Buy	8,200 +300	+4%	+$19.7K	0.03%	333
2015 Q3	$503K	Buy	7,900 +3,000	+61%	+$197K	0.03%	386
2015 Q2	$312K	Sell	4,900 -100	-2%	-$6.85K	0.01%	552
2015 Q1	$342K	Buy	+5,000	New	+$347K	0.02%	506

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CSS LLC's AZN Position: Q3 2016 in Review

CSS LLC sold out of AstraZeneca (AZN) in Q3 2016, closing a stake of 3,400 shares — an estimated $205K sold.

CSS LLC first reported a position in AZN in Q2 2014 and held it in 9 quarters. The position peaked at $1.11M in Q2 2014. 450 funds tracked by Wall St. Rank hold AZN as of Q3 2016.

CSS LLC reported no remaining AstraZeneca position as of Q3 2016 after selling out during the quarter.
CSS LLC sold 3,400 AstraZeneca shares in Q3 2016, an estimated $205K.
CSS LLC first reported a position in AstraZeneca in Q2 2014 and held it in 9 quarters.
CSS LLC's AstraZeneca position peaked at $1.11M in Q2 2014.
450 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2016.

Based on CSS LLC's 13F filing for Q3 2016, filed 14 Nov 2016.